Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News
Forge Biologics Receives QP Declaration for AAV Gene Therapy Manufacturing in Europe

Forge Biologics, a leading manufacturer of genetic medicines, today announced that its manufacturing facility has successfully completed the audits necessa...

April 24, 2023 | Monday | News
Aurisco Expands Oligonucleotide Capacity and Launches New Website

The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial olig...

April 24, 2023 | Monday | News
Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applyin...

April 21, 2023 | Friday | News
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Announced an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) (NCT045...

April 19, 2023 | Wednesday | News
South Korean Biotech, ToolGen Leads the Development of Numerous Cutting-Edge Genome Editing Techniques

The first study presents a new cell-based assay called TAgmentation of Prime Editor sequencing (TAPE-seq) that can predict genome-wide off-target candidate...

April 19, 2023 | Wednesday | News
Cytiva's X-Platform Bioreactors Boost Process Efficiency, Paving the Way for Future Biomanufacturing Breakthroughs

Global biotechnology leader builds on Xcellerex heritage to now offer X-platform bioreactors. X-platform bioreactors can be used for monoclonal antibodi...

April 19, 2023 | Wednesday | News
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol

As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At th...

April 18, 2023 | Tuesday | News
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical

In April 2022, Telix secured the exclusive worldwide rights to develop and commercialise radiolabelled forms of olaratumab for the diagnosis and treatment ...

April 17, 2023 | Monday | News
Atmo Biosciences strengthens U.S. focus with new board appointment and establishment of San Diego office

The increased presence in the U.S. comes as Atmo Biosciences prepares to begin a multi-site pivotal study to support a U.S. Food and Drug Administration (F...

April 17, 2023 | Monday | News
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions   Prometheus Biosciences&rs...

April 17, 2023 | Monday | News
Regulus Therapeutics Completes Enrollment in Phase 1b MAD Trial of RGLS8429 for ADPKD Treatment

"Completion of enrollment in the first cohort of the Phase 1b MAD study is an important milestone in the development of this novel treatment for ADPKD," sa...

April 13, 2023 | Thursday | News
FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI

Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) fo...

April 09, 2023 | Sunday | News
Bispecific Antibodies: Successes, Challenges, and Strategies

Relapsed or refractory precursor B-cell acute lymphoblastic leukemia Bleeding due to hemophilia A Non-small cell lung cancer Unresectable or metastati...

April 09, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close